Dr Agarwals Health Care Ltd
Dr Agarwals Health Care Q2 Results 2026 (FY27): Revenue ₹655 Cr, PAT ₹57 Cr
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹655Cr
- Net profit
- ₹57Cr
- Margin
- 26.8%
Guidance rank: #11 of 32 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Based on Dr Agarwals Health Care Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY27 revenue from operations: ₹655 Cr, up 31.4% YoY from ₹499 Cr in Q2 FY26 (Page 24). Quarter: Q2 FY27.
From Dr Agarwals Health Care Ltd's Q2 FY27 earnings-call transcript · updated 5 Nov 2026.
How did Dr Agarwals Health Care's revenue grow in the September 2026 quarter?
- Q2 FY27 revenue from operations: ₹655 Cr, up 31.4% YoY from ₹499 Cr in Q2 FY26 (Page 24)
- Total income for Q2 FY27: ₹665 Cr, up 31.3% YoY from ₹507 Cr in Q2 FY26 (Page 24)
- Number of surgeries performed in H1 FY27: 1,86,923 vs 1,57,281 in H1 FY26 (approx. 19% growth) (Page 48)
2 more points from Dr Agarwals Health Care Ltd's call on revenue
Create a free account to keep reading this call
What happened to Dr Agarwals Health Care's margins in Q2 FY27?
See what Dr Agarwals Health Care Ltd said on profitability & margins — free account, 30 seconds.
What capex is Dr Agarwals Health Care planning?
- Capital expenditure towards tangible and intangible assets was ₹220 Cr in H1 FY27 (Page 52).
- Network expansion includes adding more surgical facilities in H1 FY27 than all of FY26, indicating aggressive capacity expansion (Page 14).
- Expansion plans for FY27 include adding facilities in India across South, West, North, and East regions, plus plans to add a facility in Zambia and enter Ethiopia in Africa (Page 18).
2 more points from Dr Agarwals Health Care Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Dr Agarwals Health Care raising money or cutting debt?
See what Dr Agarwals Health Care Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Dr Agarwals Health Care's order book?
See what Dr Agarwals Health Care Ltd said on order book & pipeline — free account, 30 seconds.
Dr Agarwals Health Care Ltd — Quarterly revenue & net profit
Dr Agarwals Health Care Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 |
|---|---|
| Revenue | 655 |
| Operating profit (EBITDA) | 176 |
| Operating margin | 26.8% |
| Profit before tax | 80 |
| Net profit (PAT) | 57 |
| EPS (₹) | 1.65 |
Source: Dr Agarwals Health Care Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹655 Cr, net profit ₹57 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Dr Agarwal's Hea's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
Earlier calls (1)
Others in Healthcare Services this season
- Nidan Laboratories & Healthcare (Q2 FY27)
Operating Margin: Not explicitly stated as a percentage; however, total income from operations is Rs 1,201.76 lakhs, so approximate operating margin = (EBITDA…
- Suven Life Sciences (Q2 FY27)
91.92 lakhs for the quarter ended September 30, 2025, indicating a revenue increase of approximately 30.3%. Key results statement takeaways from Suven Life Scie
- Aster DM Quality (Q2 FY27)
Q2 FY27 revenue: INR 2,829 Cr, up 19% YoY from INR 2,382 Cr in Q2 FY26 (Page 6, 9, 10). Key investor presentation takeaways from Aster DM Quality Care Ltd's Q2
- Fortis Healthcare (Q2 FY27)
Q2FY27 consolidated revenue: INR 2,735 Cr, up 17.3% YoY (Q2FY26: INR 2,331 Cr) [Pages 11, 33] . Key investor presentation takeaways from Fortis Healthcare Ltd's
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM QualityGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Dr Agarwals Health Care Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Dr Agarwals Health Care Ltd Q2 FY27 results?
Q2 FY27 revenue from operations: ₹655 Cr, up 31.4% YoY from ₹499 Cr in Q2 FY26 (Page 24). Quarter: Q2 FY27.
What is Dr Agarwals Health Care Ltd share price analysis?
Dr Agarwals Health Care Ltd currently shows a neutral. The stock trades at a P/E of 109.9 with a market cap of ₹16,223 Cr. Investors should review the full earnings analysis for detailed insights.
Is Dr Agarwals Health Care Ltd planning capital expenditure?
Capital expenditure towards tangible and intangible assets was ₹220 Cr in H1 FY27 (Page 52).
Keep Dr Agarwals Health Care Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.